| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |